Dr Dana Rizk is Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham (UAB) and a VOYXACT VISIONARY Study Investigator and Co-Chair of the Steering Committee.

This press release from Healthy Kidney Inc. highlights their 2 Part Video Series on How to Lower Proteinuria in CKD Patients, focusing on dietary changes. One of the most effective ways to manage ...

Protein in urine can be a sign of kidney disease and usually there are very few proteins in the urine. Foamy urine can be a sign of proteinuria, but it can also have other causes and should be ...

Voyxact, an APRIL inhibitor, receives FDA accelerated approval for adults with primary IgA nephropathy to reduce proteinuria.

Yes, cystitis, also known as bladder inflammation, can cause protein in the urine. A urinary tract infection (UTI) is a bacterial infection that affects the urinary tract, which includes the bladder.

ACE inhibitors and angiotensin II receptor blockers (ARBs) are the mainstay agents for proteinuria. How effective is adding a statin to reduce proteinuria? Can statins be safely used in the pediatric ...

- TARPEYO (budesonide) delayed release capsules is the first and only treatment indicated to reduce proteinuria in adults with primary IgA nephropathy (IgAN) at risk of rapid disease progression, ...

IgA nephropathy can shorten life expectancy by 10 years on average. Life expectancy can depend on several factors, including kidney function at diagnosis, protein levels in the urine, age, other ...

Recurring kidney stones can be significantly reduced through simple lifestyle adjustments. Experts emphasize drinking ample ...